References
- Sweet DG, Turner M, Straňák Z, et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 2017;102(6):F497–F503.
- Johnson S, Moore T, Marlow N. Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used? Paediatric Research. 2014;75:671–674.
- Halliday HL. Surfactants: past, present and future. J Perinatol. 2008;28(1):S47–S56.
- Sinn JK, Ward MC, Henderson-Smart DJ. Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health. 2002;38(6):597–600.
- Himpens E, Van den Broeck C, Oostra A, et al. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. 2008;50(5):334–340.
- Ribeiro LA, Zachrisson HD, Schjolberg S, et al. Attention problems and language development in preterm low-birth-weight children: cross-lagged relations from 18 to 36 months. BMC Pediatr. 2011;11:59.
- Bayley N. Bayley scales of infant and toddler development. 3rd ed. San Antonio (TX): Pearson; 2006.
- Hong T, Bolisetty S, Bajuk B, et al. A population study of respiratory rehospitalisation in very preterm infants in the first 3 years of life. J Paediatr Child Health. 2016;52(7):715–721.